全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Sequential Continuous Renal Replacement Therapy and Therapeutic Plasma Exchange in Pediatric Necrotizing Hypertriglyceridemia-Induced Pancreatitis with Suspected Familial Chylomicronemia Syndrome: A Case Report

DOI: 10.4236/ojim.2026.162015, PP. 146-163

Keywords: Hypertriglyceridemia-Induced Pancreatitis, Familial Chylomicronemia Syndrome, Therapeutic Plasma Exchange, Continuous Renal Replacement Therapy, Pediatric Critical Care, Multi-Organ Dysfunction, Chylomicrons

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Hypertriglyceridemia-induced acute pancreatitis (HTG-AP) is a severe and underrecognized etiology of pancreatitis, accounting for 1% - 4% of all cases in adults, with extreme triglyceridemia raising the risk of fulminant multi-organ failure. When underlying lipoprotein lipase (LPL) deficiency is suspected—as in familial chylomicronemia syndrome (FCS)—conventional pharmacologic strategies are inherently limited, and therapeutic plasma exchange (TPE) represents the most effective currently available approach for the rapid removal of chylomicrons and triglyceride-rich lipoproteins from the circulation. Case Summary: We report a 14-year-old girl presenting with triglycerides > 14,000 mg/dL, severe necrotizing pancreatitis, acute kidney injury (AKI), mild acute respiratory distress syndrome (ARDS), and metabolic encephalopathy. No prior medical history was identified. Despite aggressive pharmacologic therapy with intravenous insulin, heparin, and fibrates, triglyceride levels remained critically elevated. Continuous renal replacement therapy (CRRT) was initiated for AKI, metabolic acidosis, and hemodynamic instability, achieving significant physiologic stabilization. However, because CRRT does not effectively clear chylomicrons, lipid levels remained dangerously high. Two urgent sessions of TPE reduced triglycerides from >14,000 mg/dL to approximately 300 mg/dL, with subsequent normalization of pancreatic enzymes and full recovery of renal, respiratory, and neurological function. The patient was discharged in good clinical condition. Conclusion: This case illustrates that CRRT and TPE fulfill distinct, non-overlapping roles in severe HTG-AP. CRRT provides essential metabolic bridge support, and TPE achieves definitive lipid clearance. When LPL deficiency is suspected, early escalation to TPE is potentially lifesaving. A high index of clinical suspicion and timely decision-making are the key determinants of outcome in this rare but catastrophic condition.

References

[1]  Tsuang, W., Navaneethan, U., Ruiz, L., Palascak, J.B. and Gelrud, A. (2009) Hypertriglyceridemic Pancreatitis: Presentation and Management. The American Journal of Gastroenterology, 104, 984-991.
https://doi.org/10.1038/ajg.2009.27
[2]  Valdivielso, P., Ramírez-Bueno, A. and Ewald, N. (2014) Current Knowledge of Hypertriglyceridemic Pancreatitis. European Journal of Internal Medicine, 25, 689-694.
https://doi.org/10.1016/j.ejim.2014.08.008
[3]  Banks, P.A., Bollen, T.L., Dervenis, C., Gooszen, H.G., Johnson, C.D., Sarr, M.G., et al. (2012) Classification of Acute Pancreatitis—2012: Revision of the Atlanta Classification and Definitions by International Consensus. Gut, 62, 102-111.
https://doi.org/10.1136/gutjnl-2012-302779
[4]  Brahm, A.J. and Hegele, R.A. (2015) Chylomicronaemia—Current Diagnosis and Future Therapies. Nature Reviews Endocrinology, 11, 352-362.
https://doi.org/10.1038/nrendo.2015.26
[5]  Falko, J.M. (2018) Familial Chylomicronemia Syndrome: A Clinical Guide for Endocrinologists. Endocrine Practice, 24, 756-763.
https://doi.org/10.4158/ep-2018-0157
[6]  Kuchay, M.S., Farooqui, K.J., Bano, T., et al. (2017) Heparin and Insulin in Hypertriglyceridemia-Associated Pancreatitis. Case Reports in Endocrinology, 2017, Article ID: 9168075.
[7]  Leaf, D.A. (2008) Chylomicronemia and the Chylomicronemia Syndrome: A Practical Approach to Management. The American Journal of Medicine, 121, 10-12.
https://doi.org/10.1016/j.amjmed.2007.10.004
[8]  Chen, J.H., Yeh, J.H., Lai, H.W. and Liao, C.S. (2004) Therapeutic Plasma Exchange in Patients with Hyperlipidemic Pancreatitis. World Journal of Gastroenterology, 10, 2272-2274.
https://doi.org/10.3748/wjg.v10.i15.2272
[9]  Joglekar, K., Brannick, B., Kadaria, D. and Sodhi, A. (2017) Therapeutic Plasmapheresis for Hypertriglyceridemia-Associated Acute Pancreatitis: Case Series and Review of the Literature. Therapeutic Advances in Endocrinology and Metabolism, 8, 59-65.
https://doi.org/10.1177/2042018817695449
[10]  Gubenšek, J., Buturović-Ponikvar, J., Marn-Pernat, A., Kovač, J., Knap, B., Premru, V., et al. (2009) Treatment of Hyperlipidemic Acute Pancreatitis with Plasma Exchange: A Single-Center Experience. Therapeutic Apheresis and Dialysis, 13, 314-317.
https://doi.org/10.1111/j.1744-9987.2009.00731.x
[11]  Schwartz, J., Padmanabhan, A., Aqui, N., Balogun, R.A., Connelly-Smith, L., Delaney, M., et al. (2016) Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. Journal of Clinical Apheresis, 31, 149-338.
https://doi.org/10.1002/jca.21470
[12]  Hu, Y., Xiong, W., Li, C. and Cui, Y. (2019) Continuous Blood Purification for Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis. Medicine, 98, e14873.
https://doi.org/10.1097/MD.0000000000014873
[13]  Ronco, C., Bellomo, R. and Kellum, J.A. (2019) Acute Kidney Injury. The Lancet, 394, 1949-1964.
https://doi.org/10.1016/s0140-6736(19)32563-2
[14]  He, W., Yu, M., Zhu, Y., Xia, L., Liu, P., Zeng, H., et al. (2016) Emergent Triglyceride-Lowering Therapy with Early High-Volume Hemofiltration against Low-Molecular-Weight Heparin Combined with Insulin in Hypertriglyceridemic Pancreatitis. Journal of Clinical Gastroenterology, 50, 772-778.
https://doi.org/10.1097/mcg.0000000000000552
[15]  Wang, H. and Yu, K.J. (2015) Sequential Blood Purification Therapy for Critical Patients with Hyperlipidemic Severe Acute Pancreatitis. World Journal of Gastroenterology, 21, 6304-6309.
https://doi.org/10.3748/wjg.v21.i20.6304
[16]  Stefanutti, C., Di Giacomo, S. and Labbadia, G. (2011) Timing Clinical Events in the Treatment of Pancreatitis and Hypertriglyceridemia with Therapeutic Plasmapheresis. Transfusion and Apheresis Science, 45, 3-7.
https://doi.org/10.1016/j.transci.2011.06.013
[17]  Lutfi, R., Huang, J. and Wong, H.R. (2012) Plasmapheresis to Treat Hypertriglyceridemia in a Child with Diabetic Ketoacidosis and Pancreatitis. Pediatrics, 129, e195-e198.
https://doi.org/10.1542/peds.2011-0217
[18]  Hegele, R.A., Ginsberg, H.N., Chapman, M.J., Nordestgaard, B.G., Kuivenhoven, J.A., Averna, M., et al. (2014) The Polygenic Nature of Hypertriglyceridaemia: Implications for Definition, Diagnosis, and Management. The Lancet Diabetes & Endocrinology, 2, 655-666.
https://doi.org/10.1016/s2213-8587(13)70191-8

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133